Literature DB >> 1748428

Cryptosporidiosis in the acquired immunodeficiency syndrome: a study of 15 autopsy cases.

T A Godwin1.   

Abstract

The pathologic changes associated with human cryptosporidiosis have not been well characterized. In this report, 15 cases of cryptosporidiosis in acquired immunodeficiency syndrome patients are described. Organisms were found in autopsy tissue specimens in 13 cases, and only in antemortem stool samples in two. Gastrointestinal/hepatobiliary distribution of organisms was as follows: small intestine (13 cases), extrahepatic bile ducts (eight), intrahepatic bile ducts (seven), large intestine (six), pancreas (five), stomach (three), and esophagus (one). At all sites, infection was usually associated with nonspecific reactive epithelial changes, architectural abnormalities such as villous flattening in the small intestine, and interstitial edema with mixed inflammatory cell infiltrates. Presence of organisms and associated mucosal injury were patchy and of variable severity in the intestine. In the biliary tract, injury was commonly diffuse and severe. Pancreatic duct injury was generally mild and often limited to hyperplastic squamous metaplasia. In late-stage acquired immunodeficiency syndrome patients with cryptosporidiosis, widespread infection in the gastrointestinal and biliary systems by this coccidian was more common and severe than previously suggested. Although the mechanisms have yet to be determined, infection usually is accompanied by pathologic changes that may be causally related to pathophysiologic abnormalities, such as diarrhea and malabsorption, and may account for other clinical manifestations of pancreatitis, cholangitis, and obstructive cholestasis.

Entities:  

Mesh:

Year:  1991        PMID: 1748428     DOI: 10.1016/0046-8177(91)90103-v

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

Review 1.  Intestinal mucosal responses to microbial infection.

Authors:  Lars Eckmann; Martin F Kagnoff
Journal:  Springer Semin Immunopathol       Date:  2005-06-01

2.  Cytotoxic T cells in AIDS colonic cryptosporidiosis.

Authors:  D Reijasse; N Patey-Mariaud de Serre; D Canioni; M Huerre; E Haddad; M Leborgne; S Blanche; N Brousse
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

3.  Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8.

Authors:  K B Seydel; T Zhang; G A Champion; C Fichtenbaum; P E Swanson; S Tzipori; J K Griffiths; S L Stanley
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS.

Authors:  W C Jordan
Journal:  J Natl Med Assoc       Date:  1996-07       Impact factor: 1.798

Review 5.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection.

Authors:  D F McCole; L Eckmann; F Laurent; M F Kagnoff
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface.

Authors:  D A Elliott; D P Clark
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.

Authors:  F J Enriquez; M W Riggs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Gastric involvement in AIDS associated cryptosporidiosis.

Authors:  P Rossi; F Rivasi; M Codeluppi; A Catania; A Tamburrini; E Righi; E Pozio
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  Accumulation of tropomyosin isoform 5 at the infection sites of host cells during Cryptosporidium invasion.

Authors:  Steven P O'Hara; Jim Jung-Ching Lin
Journal:  Parasitol Res       Date:  2006-02-15       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.